Highlights
The global Personalized Medicine (PM) Solution market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Personalized Medicine (PM) Solution is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Personalized Medicine (PM) Solution is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Personalized Medicine (PM) Solution in Oncology is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Personalized Medicine (PM) Solution include 2bPrecise, OneOme, TIGAR Health- IR2Dx, Kailos Genetics, Syapse Inc, Karius, Astarte Medical, Fabric Genomics, INC. and Orion Health, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Personalized Medicine (PM) Solution, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Personalized Medicine (PM) Solution.
The Personalized Medicine (PM) Solution market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Personalized Medicine (PM) Solution market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Personalized Medicine (PM) Solution companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
2bPrecise
OneOme
TIGAR Health- IR2Dx
Kailos Genetics
Syapse Inc
Karius
Astarte Medical
Fabric Genomics, INC.
Orion Health
2B Precise
Fabric Genomics
Pfizer
Gene 42
IBM Watson Health
Philips Healthcare
Medtronic
Nanthealth
Navican
N-of-One
PierianDx
Sunquest Information System
Tempus
Novartis
Translational Software
Biocrates Life Sciences AG
Nanostring Technologies
Thermo Fisher Scientific
Quest Diagnostics Incorporated
Segment by Type
Personalized Diagnostics
Personalized Therapies
Personalized Nutrition & Wellness
Segment by Application
Oncology
Neurosciences
Immunology
Respiratory
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Personalized Medicine (PM) Solution companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Personalized Medicine (PM) Solution Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Personalized Diagnostics
1.2.3 Personalized Therapies
1.2.4 Personalized Nutrition & Wellness
1.3 Market by Application
1.3.1 Global Personalized Medicine (PM) Solution Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Oncology
1.3.3 Neurosciences
1.3.4 Immunology
1.3.5 Respiratory
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Personalized Medicine (PM) Solution Market Perspective (2018-2029)
2.2 Personalized Medicine (PM) Solution Growth Trends by Region
2.2.1 Global Personalized Medicine (PM) Solution Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Personalized Medicine (PM) Solution Historic Market Size by Region (2018-2023)
2.2.3 Personalized Medicine (PM) Solution Forecasted Market Size by Region (2024-2029)
2.3 Personalized Medicine (PM) Solution Market Dynamics
2.3.1 Personalized Medicine (PM) Solution Industry Trends
2.3.2 Personalized Medicine (PM) Solution Market Drivers
2.3.3 Personalized Medicine (PM) Solution Market Challenges
2.3.4 Personalized Medicine (PM) Solution Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Personalized Medicine (PM) Solution Players by Revenue
3.1.1 Global Top Personalized Medicine (PM) Solution Players by Revenue (2018-2023)
3.1.2 Global Personalized Medicine (PM) Solution Revenue Market Share by Players (2018-2023)
3.2 Global Personalized Medicine (PM) Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Personalized Medicine (PM) Solution Revenue
3.4 Global Personalized Medicine (PM) Solution Market Concentration Ratio
3.4.1 Global Personalized Medicine (PM) Solution Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Personalized Medicine (PM) Solution Revenue in 2022
3.5 Personalized Medicine (PM) Solution Key Players Head office and Area Served
3.6 Key Players Personalized Medicine (PM) Solution Product Solution and Service
3.7 Date of Enter into Personalized Medicine (PM) Solution Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Personalized Medicine (PM) Solution Breakdown Data by Type
4.1 Global Personalized Medicine (PM) Solution Historic Market Size by Type (2018-2023)
4.2 Global Personalized Medicine (PM) Solution Forecasted Market Size by Type (2024-2029)
5 Personalized Medicine (PM) Solution Breakdown Data by Application
5.1 Global Personalized Medicine (PM) Solution Historic Market Size by Application (2018-2023)
5.2 Global Personalized Medicine (PM) Solution Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Personalized Medicine (PM) Solution Market Size (2018-2029)
6.2 North America Personalized Medicine (PM) Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Personalized Medicine (PM) Solution Market Size by Country (2018-2023)
6.4 North America Personalized Medicine (PM) Solution Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Personalized Medicine (PM) Solution Market Size (2018-2029)
7.2 Europe Personalized Medicine (PM) Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Personalized Medicine (PM) Solution Market Size by Country (2018-2023)
7.4 Europe Personalized Medicine (PM) Solution Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Personalized Medicine (PM) Solution Market Size (2018-2029)
8.2 Asia-Pacific Personalized Medicine (PM) Solution Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Personalized Medicine (PM) Solution Market Size by Region (2018-2023)
8.4 Asia-Pacific Personalized Medicine (PM) Solution Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Personalized Medicine (PM) Solution Market Size (2018-2029)
9.2 Latin America Personalized Medicine (PM) Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Personalized Medicine (PM) Solution Market Size by Country (2018-2023)
9.4 Latin America Personalized Medicine (PM) Solution Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Personalized Medicine (PM) Solution Market Size (2018-2029)
10.2 Middle East & Africa Personalized Medicine (PM) Solution Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Personalized Medicine (PM) Solution Market Size by Country (2018-2023)
10.4 Middle East & Africa Personalized Medicine (PM) Solution Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 2bPrecise
11.1.1 2bPrecise Company Detail
11.1.2 2bPrecise Business Overview
11.1.3 2bPrecise Personalized Medicine (PM) Solution Introduction
11.1.4 2bPrecise Revenue in Personalized Medicine (PM) Solution Business (2018-2023)
11.1.5 2bPrecise Recent Development
11.2 OneOme
11.2.1 OneOme Company Detail
11.2.2 OneOme Business Overview
11.2.3 OneOme Personalized Medicine (PM) Solution Introduction
11.2.4 OneOme Revenue in Personalized Medicine (PM) Solution Business (2018-2023)
11.2.5 OneOme Recent Development
11.3 TIGAR Health- IR2Dx
11.3.1 TIGAR Health- IR2Dx Company Detail
11.3.2 TIGAR Health- IR2Dx Business Overview
11.3.3 TIGAR Health- IR2Dx Personalized Medicine (PM) Solution Introduction
11.3.4 TIGAR Health- IR2Dx Revenue in Personalized Medicine (PM) Solution Business (2018-2023)
11.3.5 TIGAR Health- IR2Dx Recent Development
11.4 Kailos Genetics
11.4.1 Kailos Genetics Company Detail
11.4.2 Kailos Genetics Business Overview
11.4.3 Kailos Genetics Personalized Medicine (PM) Solution Introduction
11.4.4 Kailos Genetics Revenue in Personalized Medicine (PM) Solution Business (2018-2023)
11.4.5 Kailos Genetics Recent Development
11.5 Syapse Inc
11.5.1 Syapse Inc Company Detail
11.5.2 Syapse Inc Business Overview
11.5.3 Syapse Inc Personalized Medicine (PM) Solution Introduction
11.5.4 Syapse Inc Revenue in Personalized Medicine (PM) Solution Business (2018-2023)
11.5.5 Syapse Inc Recent Development
11.6 Karius
11.6.1 Karius Company Detail
11.6.2 Karius Business Overview
11.6.3 Karius Personalized Medicine (PM) Solution Introduction
11.6.4 Karius Revenue in Personalized Medicine (PM) Solution Business (2018-2023)
11.6.5 Karius Recent Development
11.7 Astarte Medical
11.7.1 Astarte Medical Company Detail
11.7.2 Astarte Medical Business Overview
11.7.3 Astarte Medical Personalized Medicine (PM) Solution Introduction
11.7.4 Astarte Medical Revenue in Personalized Medicine (PM) Solution Business (2018-2023)
11.7.5 Astarte Medical Recent Development
11.8 Fabric Genomics, INC.
11.8.1 Fabric Genomics, INC. Company Detail
11.8.2 Fabric Genomics, INC. Business Overview
11.8.3 Fabric Genomics, INC. Personalized Medicine (PM) Solution Introduction
11.8.4 Fabric Genomics, INC. Revenue in Personalized Medicine (PM) Solution Business (2018-2023)
11.8.5 Fabric Genomics, INC. Recent Development
11.9 Orion Health
11.9.1 Orion Health Company Detail
11.9.2 Orion Health Business Overview
11.9.3 Orion Health Personalized Medicine (PM) Solution Introduction
11.9.4 Orion Health Revenue in Personalized Medicine (PM) Solution Business (2018-2023)
11.9.5 Orion Health Recent Development
11.10 2B Precise
11.10.1 2B Precise Company Detail
11.10.2 2B Precise Business Overview
11.10.3 2B Precise Personalized Medicine (PM) Solution Introduction
11.10.4 2B Precise Revenue in Personalized Medicine (PM) Solution Business (2018-2023)
11.10.5 2B Precise Recent Development
11.11 Fabric Genomics
11.11.1 Fabric Genomics Company Detail
11.11.2 Fabric Genomics Business Overview
11.11.3 Fabric Genomics Personalized Medicine (PM) Solution Introduction
11.11.4 Fabric Genomics Revenue in Personalized Medicine (PM) Solution Business (2018-2023)
11.11.5 Fabric Genomics Recent Development
11.12 Pfizer
11.12.1 Pfizer Company Detail
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Personalized Medicine (PM) Solution Introduction
11.12.4 Pfizer Revenue in Personalized Medicine (PM) Solution Business (2018-2023)
11.12.5 Pfizer Recent Development
11.13 Gene 42
11.13.1 Gene 42 Company Detail
11.13.2 Gene 42 Business Overview
11.13.3 Gene 42 Personalized Medicine (PM) Solution Introduction
11.13.4 Gene 42 Revenue in Personalized Medicine (PM) Solution Business (2018-2023)
11.13.5 Gene 42 Recent Development
11.14 IBM Watson Health
11.14.1 IBM Watson Health Company Detail
11.14.2 IBM Watson Health Business Overview
11.14.3 IBM Watson Health Personalized Medicine (PM) Solution Introduction
11.14.4 IBM Watson Health Revenue in Personalized Medicine (PM) Solution Business (2018-2023)
11.14.5 IBM Watson Health Recent Development
11.15 Philips Healthcare
11.15.1 Philips Healthcare Company Detail
11.15.2 Philips Healthcare Business Overview
11.15.3 Philips Healthcare Personalized Medicine (PM) Solution Introduction
11.15.4 Philips Healthcare Revenue in Personalized Medicine (PM) Solution Business (2018-2023)
11.15.5 Philips Healthcare Recent Development
11.16 Medtronic
11.16.1 Medtronic Company Detail
11.16.2 Medtronic Business Overview
11.16.3 Medtronic Personalized Medicine (PM) Solution Introduction
11.16.4 Medtronic Revenue in Personalized Medicine (PM) Solution Business (2018-2023)
11.16.5 Medtronic Recent Development
11.17 Nanthealth
11.17.1 Nanthealth Company Detail
11.17.2 Nanthealth Business Overview
11.17.3 Nanthealth Personalized Medicine (PM) Solution Introduction
11.17.4 Nanthealth Revenue in Personalized Medicine (PM) Solution Business (2018-2023)
11.17.5 Nanthealth Recent Development
11.18 Navican
11.18.1 Navican Company Detail
11.18.2 Navican Business Overview
11.18.3 Navican Personalized Medicine (PM) Solution Introduction
11.18.4 Navican Revenue in Personalized Medicine (PM) Solution Business (2018-2023)
11.18.5 Navican Recent Development
11.19 N-of-One
11.19.1 N-of-One Company Detail
11.19.2 N-of-One Business Overview
11.19.3 N-of-One Personalized Medicine (PM) Solution Introduction
11.19.4 N-of-One Revenue in Personalized Medicine (PM) Solution Business (2018-2023)
11.19.5 N-of-One Recent Development
11.20 PierianDx
11.20.1 PierianDx Company Detail
11.20.2 PierianDx Business Overview
11.20.3 PierianDx Personalized Medicine (PM) Solution Introduction
11.20.4 PierianDx Revenue in Personalized Medicine (PM) Solution Business (2018-2023)
11.20.5 PierianDx Recent Development
11.21 Sunquest Information System
11.21.1 Sunquest Information System Company Detail
11.21.2 Sunquest Information System Business Overview
11.21.3 Sunquest Information System Personalized Medicine (PM) Solution Introduction
11.21.4 Sunquest Information System Revenue in Personalized Medicine (PM) Solution Business (2018-2023)
11.21.5 Sunquest Information System Recent Development
11.22 Tempus
11.22.1 Tempus Company Detail
11.22.2 Tempus Business Overview
11.22.3 Tempus Personalized Medicine (PM) Solution Introduction
11.22.4 Tempus Revenue in Personalized Medicine (PM) Solution Business (2018-2023)
11.22.5 Tempus Recent Development
11.23 Novartis
11.23.1 Novartis Company Detail
11.23.2 Novartis Business Overview
11.23.3 Novartis Personalized Medicine (PM) Solution Introduction
11.23.4 Novartis Revenue in Personalized Medicine (PM) Solution Business (2018-2023)
11.23.5 Novartis Recent Development
11.24 Translational Software
11.24.1 Translational Software Company Detail
11.24.2 Translational Software Business Overview
11.24.3 Translational Software Personalized Medicine (PM) Solution Introduction
11.24.4 Translational Software Revenue in Personalized Medicine (PM) Solution Business (2018-2023)
11.24.5 Translational Software Recent Development
11.25 Biocrates Life Sciences AG
11.25.1 Biocrates Life Sciences AG Company Detail
11.25.2 Biocrates Life Sciences AG Business Overview
11.25.3 Biocrates Life Sciences AG Personalized Medicine (PM) Solution Introduction
11.25.4 Biocrates Life Sciences AG Revenue in Personalized Medicine (PM) Solution Business (2018-2023)
11.25.5 Biocrates Life Sciences AG Recent Development
11.26 Nanostring Technologies
11.26.1 Nanostring Technologies Company Detail
11.26.2 Nanostring Technologies Business Overview
11.26.3 Nanostring Technologies Personalized Medicine (PM) Solution Introduction
11.26.4 Nanostring Technologies Revenue in Personalized Medicine (PM) Solution Business (2018-2023)
11.26.5 Nanostring Technologies Recent Development
11.27 Thermo Fisher Scientific
11.27.1 Thermo Fisher Scientific Company Detail
11.27.2 Thermo Fisher Scientific Business Overview
11.27.3 Thermo Fisher Scientific Personalized Medicine (PM) Solution Introduction
11.27.4 Thermo Fisher Scientific Revenue in Personalized Medicine (PM) Solution Business (2018-2023)
11.27.5 Thermo Fisher Scientific Recent Development
11.28 Quest Diagnostics Incorporated
11.28.1 Quest Diagnostics Incorporated Company Detail
11.28.2 Quest Diagnostics Incorporated Business Overview
11.28.3 Quest Diagnostics Incorporated Personalized Medicine (PM) Solution Introduction
11.28.4 Quest Diagnostics Incorporated Revenue in Personalized Medicine (PM) Solution Business (2018-2023)
11.28.5 Quest Diagnostics Incorporated Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
2bPrecise
OneOme
TIGAR Health- IR2Dx
Kailos Genetics
Syapse Inc
Karius
Astarte Medical
Fabric Genomics, INC.
Orion Health
2B Precise
Fabric Genomics
Pfizer
Gene 42
IBM Watson Health
Philips Healthcare
Medtronic
Nanthealth
Navican
N-of-One
PierianDx
Sunquest Information System
Tempus
Novartis
Translational Software
Biocrates Life Sciences AG
Nanostring Technologies
Thermo Fisher Scientific
Quest Diagnostics Incorporated
听
听
*If Applicable.
